AMPHIPROTECH
LIVE
Serial Number
79360545
Owner
Shanghai Puyou Biomedical Co., Ltd.Attorney
David M. PerryFiling Date
Nov 30, 2022
AMPHIPROTECH Trademark
Serial Number: 79360545 • Registration: 7318395
AMPHIPROTECH is a trademark filed by
Shanghai Puyou Biomedical Co., Ltd.
on November 30, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
David M. Perry Blank Rome LLP
One Logan Square
8th Floor
Philadelphia
PA 19103-6998
Trademark Details
Filing Date
November 30, 2022
Registration Date
March 5, 2024
Published for Opposition
December 19, 2023
Filing History
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Dec 19, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 29, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 29, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 9, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 28, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 28, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 15, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 24, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 20, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 19, 2023 REPR
